Literature DB >> 6609170

Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.

H Kodo, R P Gale, A Saxon.   

Abstract

Normal volunteers received either initial or booster immunization with tetanus toxoid. Bone marrow and peripheral blood mononuclear cells were obtained for up to 28 d after immunization and were analyzed for synthesis of total Ig and specific antibodies to tetanus toxoid. Cells were cultured in vitro for 3 or 7 d with or without pokeweed mitogen (PWM). Synthesis of IgG and IgM antibodies to tetanus (IgG-Tet and IgM-Tet) and total IgG and IgM was determined by radioimmunoassay. Four functional B cell subpopulations were detected in the bone marrow after booster tetanus immunization: (a) B cells that spontaneously synthesized IgG-Tet appeared on day 7 after immunization but were undetectable by day 21; (b) B cells that synthesized IgG-Tet after stimulation with PWM appeared after day 21 and persisted for greater than 1 mo; (c) B cells that synthesized IgM-Tet in the presence of PWM were detectable before and after immunization; and (d) B cells that spontaneously synthesized IgM-Tet appeared on day 7 and were undetectable by day 21. In contrast to the other three types of bone marrow B cells described, this fourth subpopulation of PWM-independent IgM-Tet-synthesizing B cells was not detected in the peripheral blood. After primary immunization, no spontaneous antibody-producing cells were detected in the blood or bone marrow, although there was a small rise in IgM-Tet in two of three subjects. In the bone marrow, only IgM-Tet PWM-inducible cells were seen, although mitogen-responsive IgM and IgG-Tet cells were detected in the circulation. The IgM-Tet PWM-reactive cells were present even before primary antigen exposure and appear to represent the initial B cells involved in the antibody response. These data indicate that there are specific times after immunization when different functional classes of anti-Tet-synthesizing B cells and memory B cells appear in human bone marrow. Knowledge of these data may be important in developing a strategy for the transfer of immune memory from donors to recipients in the setting of bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609170      PMCID: PMC425160          DOI: 10.1172/JCI111341

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Immunodeficiency following allogeneic bone marrow transplantation.

Authors:  R P Gale; G Opelz; M R Mickey; P R Graze; A Saxon
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

2.  Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors.

Authors:  D R Noel; R P Witherspoon; R Storb; K Atkinson; K Doney; E M Mickelson; H D Ochs; R P Warren; P L Weiden; E D Thomas
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

3.  Antibody formation in mouse bone marrow. IX. Peripheral lymphoid organs are involved in the initiation of bone marrow antibody formation.

Authors:  R Benner; A van Oudenaren; H de Ruiter
Journal:  Cell Immunol       Date:  1977-11       Impact factor: 4.868

4.  Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  The formation of immunoglobulins by human tissues in vitro. 3. Spleen, lymph nodes, bone marrow and thymus.

Authors:  R van Furth; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1966-07       Impact factor: 7.397

6.  Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production.

Authors:  R McMillan; R L Longmire; R Yelenosky; J E Lang; V Heath; C G Craddock
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

7.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Thymus-dependent lymphocytes in human bone marrow.

Authors:  R P Gale; G Opelz; O M Kiuchi; D W Golde
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Rheumatoid factor-producing cells detected by direct hemolytic plaque assay.

Authors:  J H Vaughan; T Chihara; T L Moore; D L Robbins; K Tanimoto; J S Johnson; R McMillan
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals.

Authors:  A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

View more
  8 in total

1.  Human in vivo-induced spontaneous IgG-secreting cells from tonsil, blood and bone marrow exhibit different phenotype and functional level of maturation.

Authors:  J A Brieva; E Roldán; M L De la Sen; C Rodriguez
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Designed transfer of specific immune responses with bone marrow transplantation.

Authors:  A Saxon; R Mitsuyasu; R Stevens; R E Champlin; H Kimata; R P Gale
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.

Authors:  L G Lum; E Burns; M M Janson; P J Martin; B R Giddings; M C Seigneuret; J E Noges; S C Galoforo
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

4.  Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus.

Authors:  Y Ueki; I S Goldfarb; N Harindranath; M Gore; H Koprowski; A L Notkins; P Casali
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

5.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

6.  Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Authors:  M Benkerrou; D W Wara; M Elder; Y Dror; A Merino; B W Colombe; M Garovoy; M J Cowan
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

7.  Impaired antipneumococcal antibody production in patients without spleens.

Authors:  F Di Padova; M Dürig; F Harder; C Di Padova; C Zanussi
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

8.  VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion.

Authors:  E Roldán; A García-Pardo; J A Brieva
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.